176 related articles for article (PubMed ID: 14667588)
1. Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer.
Ichinose Y; Fukuyama Y; Asoh H; Ushijima C; Okamoto T; Ikeda J; Okamoto J; Sakai M
Ann Thorac Surg; 2003 Dec; 76(6):1810-4; discussion 1815. PubMed ID: 14667588
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.
Maruyama R; Hirai F; Ondo K; Kometani T; Hamatake M; Seto T; Sugio K; Ichinose Y
Surg Today; 2011 Nov; 41(11):1492-7. PubMed ID: 21969151
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC).
Saito J; Nakai Y; Saijo Y; Nukiwa T; Koinumaru S; Matsuura Y; Aso N; Yamane Y; Tsukamoto T; Sayama T; Nakabayashi T
Lung Cancer; 2001; 31(2-3):285-93. PubMed ID: 11165409
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
Rusch VW; Albain KS; Crowley JJ; Rice TW; Lonchyna V; McKenna R; Livingston RB; Griffin BR; Benfield JR
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
[TBL] [Abstract][Full Text] [Related]
6. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
[TBL] [Abstract][Full Text] [Related]
7. Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.
Ichinose Y; Nakai Y; Kudoh S; Semba H; Yoshida S; Nukiwa T; Yamamoto H; Yamane Y; Niitani H
Clin Cancer Res; 2004 Jul; 10(13):4369-73. PubMed ID: 15240524
[TBL] [Abstract][Full Text] [Related]
8. UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study Group.
Ichinose Y; Yosimori K; Yoneda S; Kuba M; Kudoh S; Niitani H
Cancer; 2000 Jan; 88(2):318-23. PubMed ID: 10640963
[TBL] [Abstract][Full Text] [Related]
9. UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Ichinose Y; Yano T; Asoh H; Yokoyama H; Maruyama R; Ushijima C; Uehara T; Kanematsu T; Yohena T; Wada S
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):98-101. PubMed ID: 10442374
[TBL] [Abstract][Full Text] [Related]
10. Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
Juan O; Sánchez-Hernández A; Vázquez S; Casal J; Firvida JL; Aparisi F; Muñoz J; García-Sánchez J; Gironés R; Lázaro M; Giner V
Anticancer Res; 2014 Apr; 34(4):1959-66. PubMed ID: 24692732
[TBL] [Abstract][Full Text] [Related]
11. Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach.
Galetta D; Cesario A; Margaritora S; Porziella V; Macis G; D'Angelillo RM; Trodella L; Sterzi S; Granone P
Ann Thorac Surg; 2003 Dec; 76(6):1802-8; discussion 1808-9. PubMed ID: 14667587
[TBL] [Abstract][Full Text] [Related]
12. S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
Ichinose Y; Seto T; Sasaki T; Yamanaka T; Okamoto I; Takeda K; Tanaka M; Katakami N; Sawa T; Kudoh S; Saka H; Nishimura Y; Nakagawa K; Fukuoka M
J Thorac Oncol; 2011 Dec; 6(12):2069-75. PubMed ID: 22052226
[TBL] [Abstract][Full Text] [Related]
13. Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.
Yamaguchi M; Toyokawa G; Ohba T; Sasaki T; Kometani T; Hamatake M; Hirai F; Taguchi K; Yamanaka T; Seto T; Takenoyama M; Sugio K; Ichinose Y
Ann Thorac Surg; 2013 Nov; 96(5):1783-9. PubMed ID: 23998404
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
15. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
[TBL] [Abstract][Full Text] [Related]
17. A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801).
Kawaguchi K; Yokoi K; Niwa H; Ohde Y; Mori S; Okumura S; Shiono S; Ito H; Yano M; Shigemitsu K; Hiramatsu Y; Okami J; Saka H;
Lung Cancer; 2017 Feb; 104():79-84. PubMed ID: 28213006
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.
Kato M; Onishi H; Matsumoto K; Tsuruta N; Higuchi K; Motoshita J; Katano M
Anticancer Res; 2012 Nov; 32(11):5099-104. PubMed ID: 23155287
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer.
Ichinose Y; Takanashi N; Yano T; Asoh H; Yokoyama H; Tayama K; Hara N; Ohta M
Cancer; 1995 Jun; 75(11):2677-80. PubMed ID: 7743469
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601.
Sugawara S; Maemondo M; Tachihara M; Inoue A; Ishimoto O; Sakakibara T; Usui K; Watanabe H; Matsubara N; Watanabe K; Kanazawa K; Ishida T; Saijo Y; Nukiwa T;
Lung Cancer; 2013 Jul; 81(1):91-6. PubMed ID: 23643176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
